Aller au contenu principal
Accès ouvert déclaré 2024 conference-paper

Optimising methods for human thyroid primary cell culture isolation

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

According to the GLOBOCAN 2020 database on cancer incidence and mortality, thyroid cancer (TC) has the ninth-highest cancer in- cidence worldwide. Basic research contributes to developing diag- nostic and treatment alternatives. Cell models play a crucial role in vitro study of the thyroid. Permanent thyroid cell lines widely used in laboratory research typically originate from tumors. However, there is a need to compare these tumor cells with cells originating from normal thyroid tissue. Primary cell lines are invaluable for exploring cancer biology and investigating novel treatments. This study aims is optimize an isolation protocol of human primary thyroid cells from histologically non-tumor, tumor, and metastasis tissues. Primary cul- tures are laborious to obtain and then difficult to maintain in culture. We tried five different methods for isolating primary cells that com- bine mechanical disaggregation and enzymatic digestion. These methods use distinct enzymatic compositions, incubation times, and mechanical approaches, including centrifugation. We have ar- rived at a simple, rapid, and effective method to culture cells from thyroid biopsies for subsequent studies. Our previous results have revealed that GEF-H1 plays a pro-tumor role in different tumoral cell lines. We investigate the expression of GEF-H1, which belongs to the RhoA-GTPase activator family, in primary cells. Using immu- nofluorescence staining, we observed significantly higher GEF-H1 protein expression in cytokeratin-19 positive thyroid carcinoma cells compared to normal thyroid cells (p<0.0001). Our results propose a cheap and easy isolation thyroid primary cells protocol and suggest that GEF-H1 could be used as a potential tumor biomarker in TC.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

Aucun DOI disponible pour le contrôle Crossref.

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.